SFig 1 : Ce DRs 
[DoseResponses/Celegans: Ce_DR.tiff] 

Fig1: Ce QTL/split 
[LinkageMapping/Celegans: Ce_Linkage.tiff]

STable 1: Ce QTL details
[LinkageMapping/Celegans: Ce_Linkage.csv]

SFig2: Ce QTL grouped by drug and trait 
[LinkageMapping/Celegans: Ce_Linkage_Grouped.tiff]

SFig3: Ce trait correlations
[LinkageMapping/Celegans: Ce_Correlation.tiff]

SFig4: Ce ben-1 effect size
[Celegans_other/ben1: ben1.tiff]

Fig2: Ce NIL narrowing and interval annotation
[Celegans_other/QTLnarrow: QTLinterval.tiff]

STable2: Ce QTL protein-coding variants (high/moderate)
[Celegans_other/QTLnarrow: Ce_QTL_protvars.csv]

STable3: Ce QTL piRNA genes
[Celegans_other/QTLnarrow: Ce_QTL_piRNAvars.csv]

Fig3: Ce NILs, mutants, RNA-seq
CeNILS/mutants: [Celegans_other/piRNA:]
RNAseq candidates: [RNApipeline/targets]

STable4: Strain-specific putative piRNAs
[RNApipeline/targets/seq_21unique: Unique21mers.csv]

STable5: Predicted targets / seq information
RNAseq candidates: [RNApipeline/targets]

SFig5: Cb DRs 
[DoseResponses/Cbriggsae: Cb_DR.tiff]

SFig6: Cb trait correlations
[LinkageMapping/Cbriggsae: Cb_Correlation.tiff]

SFig7: Cb QTL/split
[LinkageMapping/Cbriggsae: Cb_Linkage2.tiff]

STable6: Cb QTL details
[LinkageMapping/Cbriggsae: Cb_Linkage.csv]

STable7: Cb variants and effects
[LinkageMapping/Cbriggsae: Cb_QTL_vars.csv]

STable8: Parasite Orthologs (referenced in Methods)
[Celegans_other/Parasite_orthologs: ceQTLvars-final.csv]


---

"Supplemental Methods" referenced as a whole in the main manuscript and methods sections

SuppMethods1: Sorter Assay

SuppMethods2: Bioinformatics pipeline (replace)

SuppMethods3: NILS/mutants
